| Year |
Citation |
Score |
| 2020 |
van Westrhenen R, Aitchison KJ, Ingelman-Sundberg M, Jukić MM. Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going? Frontiers in Psychiatry. 11: 94. PMID 32226396 DOI: 10.3389/Fpsyt.2020.00094 |
0.341 |
|
| 2019 |
Lodhi RJ, Wang Y, Macintyre G, Crocker C, Loverock A, Henriques BC, Heywood B, Sivapalan S, Bowker A, Majeau B, Bolt C, Bugbee D, Newton V, Tibbo P, Purdon SE, ... Aitchison KJ, et al. Trend level gene-gender interaction effect for the BDNF rs6265 variant on age of onset of psychosis. Psychiatry Research. 280: 112500. PMID 31445421 DOI: 10.1016/J.Psychres.2019.112500 |
0.324 |
|
| 2019 |
Madsen T, Buttenschøn HN, Uher R, Behrendt-Møller I, Perroud N, Maier W, Hauser J, Dernovsek MZ, Henigsberg N, Souery D, Rietschel M, McGuffin P, Aitchison KJ, Mors O, Köhler-Forsberg O. Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder. The Journal of Clinical Psychiatry. 80. PMID 31318184 DOI: 10.4088/Jcp.18M12575 |
0.315 |
|
| 2019 |
Leirer DJ, Iyegbe CO, Di Forti M, Patel H, Carra E, Fraietta S, Colizzi M, Mondelli V, Quattrone D, Lally J, Ajnakina O, Lee SH, Curtis CJ, Breen G, Pariante C, ... Aitchison K, et al. Differential gene expression analysis in blood of first episode psychosis patients. Schizophrenia Research. PMID 31113746 DOI: 10.1016/J.Schres.2019.05.011 |
0.314 |
|
| 2019 |
Bin Wei Y, McCarthy M, Ren H, Carrillo-Roa T, Shekhtman T, DeModena A, Liu JJ, Leckband SG, Mors O, Rietschel M, Henigsberg N, Cattaneo A, Binder EB, Aitchison KJ, Kelsoe JR. A functional variant in the serotonin receptor 7 gene (HTR7), rs7905446, is associated with good response to SSRIs in bipolar and unipolar depression. Molecular Psychiatry. PMID 30874608 DOI: 10.1038/S41380-019-0397-1 |
0.429 |
|
| 2019 |
Köhler-Forsberg O, Larsen ER, Buttenschøn HN, Rietschel M, Hauser J, Souery D, Maier W, Farmer A, McGuffin P, Aitchison KJ, Uher R, Mors O. Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder. The British Journal of Psychiatry : the Journal of Mental Science. 1-8. PMID 30698114 DOI: 10.1192/Bjp.2018.302 |
0.331 |
|
| 2019 |
Zwicker A, Fabbri C, Gaston D, Denovan-Wright EM, Aitchison K, Peter M, Lewis CM, Perlis R, Castro V, Uher R. GENETIC DETERMINANTS OF WEIGHT CHANGE DURING ANTIDEPRESSANT TREATMENT WITH SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS: GENOME-WIDE STUDY AND META-ANALYSIS European Neuropsychopharmacology. 29: S1000. DOI: 10.1016/J.Euroneuro.2017.08.390 |
0.363 |
|
| 2019 |
Ren H, Fabbri C, Uher R, Rietschel M, Mors O, Henigsberg N, Hauser J, Maier W, Farmer A, McGuffin P, Lewis C, Aitchison K. Genome-Wide Association Study Of Anhedonia In Gendep Using A Linear Mixed Model Identifies Candidates With Relevant Biological Function European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2017.08.345 |
0.378 |
|
| 2018 |
Fabbri C, Tansey KE, Perlis RH, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Breen G, Curtis C, Lee SH, Newhouse S, Patel H, ... ... Aitchison KJ, et al. Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 28: 945-954. PMID 30135031 DOI: 10.1016/J.Euroneuro.2018.05.009 |
0.354 |
|
| 2018 |
Zwicker A, Fabbri C, Rietschel M, Hauser J, Mors O, Maier W, Zobel A, Farmer A, Aitchison KJ, McGuffin P, Lewis CM, Uher R. Genetic disposition to inflammation and response to antidepressants in major depressive disorder. Journal of Psychiatric Research. 105: 17-22. PMID 30130674 DOI: 10.1016/J.Jpsychires.2018.08.011 |
0.345 |
|
| 2018 |
Ren H, Fabbri C, Uher R, Rietschel M, Mors O, Henigsberg N, Hauser J, Zobel A, Maier W, Dernovsek MZ, Souery D, Cattaneo A, Breen G, Craig IW, Farmer AE, ... ... Aitchison KJ, et al. Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP). Translational Psychiatry. 8: 150. PMID 30104601 DOI: 10.1038/S41398-018-0198-3 |
0.404 |
|
| 2018 |
Iniesta R, Hodgson K, Stahl D, Malki K, Maier W, Rietschel M, Mors O, Hauser J, Henigsberg N, Dernovsek MZ, Souery D, Dobson R, Aitchison KJ, Farmer A, McGuffin P, et al. Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables. Scientific Reports. 8: 5530. PMID 29615645 DOI: 10.1038/S41598-018-23584-Z |
0.323 |
|
| 2017 |
Lodhi RJ, Wang Y, Rossolatos D, MacIntyre G, Bowker A, Crocker C, Ren H, Dimitrijevic A, Bugbee DA, Loverock A, Majeau B, Sivapalan S, Newton VM, Tibbo P, Purdon SE, ... Aitchison KJ, et al. Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis use. Brain and Behavior. 7: e00850. PMID 29201551 DOI: 10.1002/Brb3.850 |
0.331 |
|
| 2017 |
Fabbri C, Tansey KE, Perlis RH, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Breen G, Curtis C, Sang-Hyuk L, Newhouse S, Patel H, ... ... Aitchison KJ, et al. New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation. The Pharmacogenomics Journal. PMID 29160301 DOI: 10.1038/Tpj.2017.44 |
0.412 |
|
| 2017 |
Ren H, Guan L, Zhao L, Lin Y, Wang Y, Yang Z, Li X, Ma X, Cheng X, Deng W, Aitchison KJ, Cao L, Li T. Contribution of genes in the GABAergic pathway to bipolar disorder and its executive function deficit in the Chinese Han population. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 29135068 DOI: 10.1002/Ajmg.B.32601 |
0.366 |
|
| 2017 |
Rivera M, Locke AE, Corre T, Czamara D, Wolf C, Ching-Lopez A, Milaneschi Y, Kloiber S, Cohen-Woods S, Rucker J, Aitchison KJ, Bergmann S, Boomsma DI, Craddock N, Gill M, et al. Interaction between the FTO gene, body mass index and depression: meta-analysis of 13701 individuals. The British Journal of Psychiatry : the Journal of Mental Science. PMID 28642257 DOI: 10.1192/Bjp.Bp.116.183475 |
0.356 |
|
| 2017 |
Köhler-Forsberg O, Buttenschøn HN, Tansey KE, Maier W, Hauser J, Dernovsek MZ, Henigsberg N, Souery D, Farmer A, Rietschel M, McGuffin P, Aitchison KJ, Uher R, Mors O. Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression. Brain, Behavior, and Immunity. PMID 28257825 DOI: 10.1016/J.Bbi.2017.02.020 |
0.322 |
|
| 2017 |
García-González J, Tansey KE, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Žagar T, Czerski PM, Jerman B, Buttenschøn HN, Schulze TG, Zobel A, ... ... Aitchison KJ, et al. Pharmacogenetics of antidepressant response: A polygenic approach. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 28159590 DOI: 10.1016/J.Pnpbp.2017.01.011 |
0.349 |
|
| 2016 |
Vassos E, Di Forti M, Coleman J, Iyegbe C, Prata D, Euesden J, O'Reilly P, Curtis C, Kolliakou A, Patel H, Newhouse S, Traylor M, Ajnakina O, Mondelli V, Marques TR, ... ... Aitchison KJ, et al. An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode Psychosis. Biological Psychiatry. PMID 27765268 DOI: 10.1016/J.Biopsych.2016.06.028 |
0.312 |
|
| 2016 |
Trotta A, Iyegbe C, Di Forti M, Sham PC, Campbell DD, Cherny SS, Mondelli V, Aitchison KJ, Murray RM, Vassos E, Fisher HL. Interplay between Schizophrenia Polygenic Risk Score and Childhood Adversity in First-Presentation Psychotic Disorder: A Pilot Study. Plos One. 11: e0163319. PMID 27648571 DOI: 10.1371/Journal.Pone.0163319 |
0.347 |
|
| 2016 |
Iniesta R, Malki K, Maier W, Rietschel M, Mors O, Hauser J, Henigsberg N, Dernovsek MZ, Souery D, Stahl D, Dobson R, Aitchison KJ, Farmer A, Lewis CM, McGuffin P, et al. Combining clinical variables to optimize prediction of antidepressant treatment outcomes. Journal of Psychiatric Research. 78: 94-102. PMID 27089522 DOI: 10.1016/J.Jpsychires.2016.03.016 |
0.303 |
|
| 2015 |
Hodgson K, Tansey KE, Powell TR, Coppola G, Uher R, Zvezdana Dernovšek M, Mors O, Hauser J, Souery D, Maier W, Henigsberg N, Rietschel M, Placentino A, Aitchison KJ, Craig IW, et al. Transcriptomics and the mechanisms of antidepressant efficacy. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26621261 DOI: 10.1016/J.Euroneuro.2015.10.009 |
0.349 |
|
| 2015 |
Rucker JJ, Tansey KE, Rivera M, Pinto D, Cohen-Woods S, Uher R, Aitchison KJ, Craddock N, Owen MJ, Jones L, Jones I, Korszun A, Barnes MR, Preisig M, Mors O, et al. Phenotypic Association Analyses with Copy Number Variation in Recurrent Depressive Disorder. Biological Psychiatry. PMID 25861698 DOI: 10.1016/J.Biopsych.2015.02.025 |
0.337 |
|
| 2015 |
Colizzi M, Iyegbe C, Powell J, Ursini G, Porcelli A, Bonvino A, Taurisano P, Romano R, Masellis R, Blasi G, Morgan C, Aitchison K, Mondelli V, Luzi S, Kolliakou A, et al. Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis. Schizophrenia Bulletin. PMID 25829376 DOI: 10.1093/Schbul/Sbv032 |
0.347 |
|
| 2015 |
Hodgson K, Tansey KE, Uher R, Dernovšek MZ, Mors O, Hauser J, Souery D, Maier W, Henigsberg N, Rietschel M, Placentino A, Craig IW, Aitchison KJ, Farmer AE, Dobson RJ, et al. Exploring the role of drug-metabolising enzymes in antidepressant side effects. Psychopharmacology. 232: 2609-17. PMID 25761838 DOI: 10.1007/S00213-015-3898-X |
0.363 |
|
| 2015 |
Legge RM, Sendi S, Cole JH, Cohen-Woods S, Costafreda SG, Simmons A, Farmer AE, Aitchison KJ, McGuffin P, Fu CH. Modulatory effects of brain-derived neurotrophic factor Val66Met polymorphism on prefrontal regions in major depressive disorder. The British Journal of Psychiatry : the Journal of Mental Science. 206: 379-84. PMID 25745134 DOI: 10.1192/Bjp.Bp.113.143529 |
0.332 |
|
| 2015 |
Ferentinos P, Koukounari A, Power R, Rivera M, Uher R, Craddock N, Owen MJ, Korszun A, Jones L, Jones I, Gill M, Rice JP, Ising M, Maier W, Mors O, ... ... Aitchison KJ, et al. Familiality and SNP heritability of age at onset and episodicity in major depressive disorder. Psychological Medicine. 1-11. PMID 25698070 DOI: 10.1017/S0033291715000215 |
0.331 |
|
| 2014 |
Mullins N, Hodgson K, Tansey KE, Perroud N, Maier W, Mors O, Rietschel M, Hauser J, Henigsberg N, Souery D, Aitchison K, Farmer A, McGuffin P, Breen G, Uher R, et al. Investigation of blood mRNA biomarkers for suicidality in an independent sample. Translational Psychiatry. 4: e474. PMID 25350297 DOI: 10.1038/Tp.2014.112 |
0.328 |
|
| 2014 |
Vyas NS, Ahn K, Stahl DR, Caviston P, Simic M, Netherwood S, Puri BK, Lee Y, Aitchison KJ. Association of KIBRA rs17070145 polymorphism with episodic memory in the early stages of a human neurodevelopmental disorder. Psychiatry Research. 220: 37-43. PMID 25146696 DOI: 10.1016/J.Psychres.2014.07.024 |
0.324 |
|
| 2014 |
Hung CF, Rivera M, Craddock N, Owen MJ, Gill M, Korszun A, Maier W, Mors O, Preisig M, Rice JP, Rietschel M, Jones L, Middleton L, Aitchison KJ, Davis OS, et al. Relationship between obesity and the risk of clinically significant depression: Mendelian randomisation study. The British Journal of Psychiatry : the Journal of Mental Science. 205: 24-8. PMID 24809401 DOI: 10.1192/Bjp.Bp.113.130419 |
0.346 |
|
| 2014 |
Bernier D, Macintyre G, Bartha R, Hanstock CC, McAllindon D, Cox D, Purdon S, Aitchison KJ, Rusak B, Tibbo PG. NPAS3 variants in schizophrenia: a neuroimaging study. Bmc Medical Genetics. 15: 37. PMID 24674381 DOI: 10.1186/1471-2350-15-37 |
0.351 |
|
| 2014 |
Koola MM, Tsapakis EM, Wright P, Smith S, Kerwin Rip RW, Nugent KL, Aitchison KJ. Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites? Journal of Psychopharmacology (Oxford, England). 28: 665-670. PMID 24595968 DOI: 10.1177/0269881114523861 |
0.315 |
|
| 2014 |
Tsapakis EM, Fernandes C, Moran-Gates T, Basu A, Sugden K, Aitchison KJ, Tarazi FI. Effects of antidepressant drug exposure on gene expression in the developing cerebral cortex. Synapse (New York, N.Y.). 68: 209-20. PMID 24458505 DOI: 10.1002/Syn.21732 |
0.322 |
|
| 2014 |
Tansey KE, Rucker JJ, Kavanagh DH, Guipponi M, Perroud N, Bondolfi G, Domenici E, Evans DM, Hauser J, Henigsberg N, Jerman B, Maier W, Mors O, O'Donovan M, Peters TJ, ... ... Aitchison KJ, et al. Copy number variants and therapeutic response to antidepressant medication in major depressive disorder. The Pharmacogenomics Journal. 14: 395-9. PMID 24445990 DOI: 10.1038/Tpj.2013.51 |
0.386 |
|
| 2014 |
Hodgson K, Uher R, Crawford AA, Lewis G, O'Donovan MC, Keers R, Dernovsek MZ, Mors O, Hauser J, Souery D, Maier W, Henigsberg N, Rietschel M, Placentino A, Aitchison K, et al. Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study. Journal of Psychopharmacology (Oxford, England). 28: 142-50. PMID 24414086 DOI: 10.1177/0269881113517957 |
0.413 |
|
| 2014 |
Hodgson K, Tansey K, Dernovsek MZ, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Smith R, Craig IW, Farmer AE, Aitchison KJ, Belsy S, et al. Genetic differences in cytochrome P450 enzymes and antidepressant treatment response. Journal of Psychopharmacology (Oxford, England). 28: 133-41. PMID 24257813 DOI: 10.1177/0269881113512041 |
0.364 |
|
| 2013 |
Power RA, Cohen-Woods S, Ng MY, Butler AW, Craddock N, Korszun A, Jones L, Jones I, Gill M, Rice JP, Maier W, Zobel A, Mors O, Placentino A, Rietschel M, ... Aitchison KJ, et al. Genome-wide association analysis accounting for environmental factors through propensity-score matching: application to stressful live events in major depressive disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 162: 521-9. PMID 23857890 DOI: 10.1002/Ajmg.B.32180 |
0.327 |
|
| 2013 |
Costafreda SG, McCann P, Saker P, Cole JH, Cohen-Woods S, Farmer AE, Aitchison KJ, McGuffin P, Fu CH. Modulation of amygdala response and connectivity in depression by serotonin transporter polymorphism and diagnosis. Journal of Affective Disorders. 150: 96-103. PMID 23643106 DOI: 10.1016/J.Jad.2013.02.028 |
0.375 |
|
| 2013 |
Powell TR, Schalkwyk LC, Heffernan AL, Breen G, Lawrence T, Price T, Farmer AE, Aitchison KJ, Craig IW, Danese A, Lewis C, McGuffin P, Uher R, Tansey KE, D'Souza UM. Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1105-14. PMID 23142150 DOI: 10.1016/J.Euroneuro.2012.09.009 |
0.318 |
|
| 2013 |
Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison KJ, Craig IW, Anacker C, Zunsztain PA, McGuffin P, Pariante CM. Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 377-85. PMID 22990943 DOI: 10.1038/Npp.2012.191 |
0.305 |
|
| 2013 |
Rucker JJ, Breen G, Pinto D, Pedroso I, Lewis CM, Cohen-Woods S, Uher R, Schosser A, Rivera M, Aitchison KJ, Craddock N, Owen MJ, Jones L, Jones I, Korszun A, et al. Genome-wide association analysis of copy number variation in recurrent depressive disorder. Molecular Psychiatry. 18: 183-9. PMID 22042228 DOI: 10.1038/Mp.2011.144 |
0.351 |
|
| 2013 |
Uher R, Tansey KE, Rietschel M, Henigsberg N, Maier W, Mors O, Hauser J, Placentino A, Souery D, Farmer A, Aitchison KJ, Craig I, McGuffin P, Lewis CM, Ising M, et al. Common genetic variation and antidepressant efficacy in major depressive disorder: A meta-analysis of three genome-wide pharmacogenetic studies American Journal of Psychiatry. 170: 207-217. DOI: 10.1176/Appi.Ajp.2012.12020237 |
0.373 |
|
| 2013 |
Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison KJ, Craig IW, Anacker C, Zunsztain PA, McGuffin P, Pariante CM. Erratum: Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ‘Predictors’ and Longitudinal ‘Targets’ Neuropsychopharmacology. 38: 376-376. DOI: 10.1038/Npp.2012.211 |
0.318 |
|
| 2013 |
Hodgson K, Tansey K, Uher R, Daivs O, Aitchison K, McGuffin P. P.4.002 Genetic differences in drug-metabolising enzymes: can they be used to predict antidepressant treatment response? European Neuropsychopharmacology. 23: S69-S70. DOI: 10.1016/S0924-977X(13)70077-4 |
0.313 |
|
| 2012 |
Tansey KE, Guipponi M, Perroud N, Bondolfi G, Domenici E, Evans D, Hall SK, Hauser J, Henigsberg N, Hu X, Jerman B, Maier W, Mors O, O'Donovan M, Peters TJ, ... ... Aitchison KJ, et al. Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis. Plos Medicine. 9: e1001326. PMID 23091423 DOI: 10.1371/Journal.Pmed.1001326 |
0.39 |
|
| 2012 |
Power RA, Keers R, Ng MY, Butler AW, Uher R, Cohen-Woods S, Ising M, Craddock N, Owen MJ, Korszun A, Jones L, Jones I, Gill M, Rice JP, Hauser J, ... ... Aitchison KJ, et al. Dissecting the genetic heterogeneity of depression through age at onset. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 159: 859-68. PMID 22915352 DOI: 10.1002/Ajmg.B.32093 |
0.366 |
|
| 2012 |
Keers R, Pedroso I, Breen G, Aitchison KJ, Nolan PM, Cichon S, Nöthen MM, Rietschel M, Schalkwyk LC, Fernandes C. Reduced anxiety and depression-like behaviours in the circadian period mutant mouse afterhours. Plos One. 7: e38263. PMID 22719873 DOI: 10.1371/Journal.Pone.0038263 |
0.346 |
|
| 2012 |
Cole J, Chaddock CA, Farmer AE, Aitchison KJ, Simmons A, McGuffin P, Fu CH. White matter abnormalities and illness severity in major depressive disorder. The British Journal of Psychiatry : the Journal of Mental Science. 201: 33-9. PMID 22576724 DOI: 10.1192/Bjp.Bp.111.100594 |
0.315 |
|
| 2012 |
Aitchison KJ, Tsapakis EM, Huezo-Diaz P, Kerwin RW, Forsling ML, Wolff K. Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT. Journal of Psychopharmacology (Oxford, England). 26: 408-18. PMID 22303032 DOI: 10.1177/0269881111434624 |
0.524 |
|
| 2012 |
Wolff K, Tsapakis EM, Pariante CM, Kerwin RW, Forsling ML, Aitchison KJ. Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption. Journal of Psychopharmacology (Oxford, England). 26: 419-28. PMID 21969106 DOI: 10.1177/0269881111415737 |
0.527 |
|
| 2012 |
Uher R, Perlis RH, Henigsberg N, Zobel A, Rietschel M, Mors O, Hauser J, Dernovsek MZ, Souery D, Bajs M, Maier W, Aitchison KJ, Farmer A, McGuffin P. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychological Medicine. 42: 967-80. PMID 21929846 DOI: 10.1017/S0033291711001905 |
0.329 |
|
| 2012 |
Huezo-Diaz P, Perroud N, Spencer EP, Smith R, Sim S, Virding S, Uher R, Gunasinghe C, Gray J, Campbell D, Hauser J, Maier W, Marusic A, Rietschel M, Perez J, ... ... Aitchison KJ, et al. CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP. Journal of Psychopharmacology (Oxford, England). 26: 398-407. PMID 21926427 DOI: 10.1177/0269881111414451 |
0.329 |
|
| 2012 |
Rivera M, Cohen-Woods S, Kapur K, Breen G, Ng MY, Butler AW, Craddock N, Gill M, Korszun A, Maier W, Mors O, Owen MJ, Preisig M, Bergmann S, Tozzi F, ... ... Aitchison KJ, et al. Depressive disorder moderates the effect of the FTO gene on body mass index. Molecular Psychiatry. 17: 604-11. PMID 21502950 DOI: 10.1038/Mp.2011.45 |
0.371 |
|
| 2012 |
Perroud N, Uher R, Ng MY, Guipponi M, Hauser J, Henigsberg N, Maier W, Mors O, Gennarelli M, Rietschel M, Souery D, Dernovsek MZ, Stamp AS, Lathrop M, Farmer A, ... ... Aitchison KJ, et al. Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project. The Pharmacogenomics Journal. 12: 68-77. PMID 20877300 DOI: 10.1038/Tpj.2010.70 |
0.372 |
|
| 2012 |
Cattaneo A, Gennarelli M, Rudolf U, Breen G, Farmer A, Aitchison KJ, Anacker C, Zunsztain PA, McGuffin P, Pariante CM. P.2.c.028 Candidate genes expression profile associated with antidepressants response: baseline predictors and longitudinal targets European Neuropsychopharmacology. 22. DOI: 10.1016/S0924-977X(12)70401-7 |
0.315 |
|
| 2012 |
Palaniyappan L, Balain V, Simmonite M, Carrol L, McGuffin P, Aitchison K, Liddle PF. Poster #108 THE INFLUENCE OF DISC1 SER704CYS POLYMORPHISM ON THE CORTICAL THICKNESS OF SALIENCE NETWORK (INSULA AND ANTERIOR CINGULATE) IN PSYCHOSIS Schizophrenia Research. 136: S319. DOI: 10.1016/S0920-9964(12)70941-6 |
0.376 |
|
| 2011 |
Uher R, Mors O, Rietschel M, Rajewska-Rager A, Petrovic A, Zobel A, Henigsberg N, Mendlewicz J, Aitchison KJ, Farmer A, McGuffin P. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study. The Journal of Clinical Psychiatry. 72: 1478-84. PMID 22127194 DOI: 10.4088/Jcp.10M06419 |
0.34 |
|
| 2011 |
Schosser A, Butler AW, Ising M, Perroud N, Uher R, Ng MY, Cohen-Woods S, Craddock N, Owen MJ, Korszun A, Jones L, Jones I, Gill M, Rice JP, Maier W, ... ... Aitchison KJ, et al. Genomewide association scan of suicidal thoughts and behaviour in major depression. Plos One. 6: e20690. PMID 21750702 DOI: 10.1371/Journal.Pone.0020690 |
0.361 |
|
| 2011 |
Uher R, Dernovsek MZ, Mors O, Hauser J, Souery D, Zobel A, Maier W, Henigsberg N, Kalember P, Rietschel M, Placentino A, Mendlewicz J, Aitchison KJ, McGuffin P, Farmer A. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. Journal of Affective Disorders. 132: 112-20. PMID 21411156 DOI: 10.1016/J.Jad.2011.02.014 |
0.305 |
|
| 2011 |
Strohmaier J, Wüst S, Uher R, Henigsberg N, Mors O, Hauser J, Souery D, Zobel A, Dernovsek MZ, Streit F, Schmäl C, Kozel D, Placentino A, Farmer A, McGuffin P, ... Aitchison KJ, et al. Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 12: 528-38. PMID 21388237 DOI: 10.3109/15622975.2011.559270 |
0.344 |
|
| 2011 |
Keers R, Aitchison KJ. Pharmacogenetics of antidepressant response. Expert Review of Neurotherapeutics. 11: 101-25. PMID 21158559 DOI: 10.1586/Ern.10.186 |
0.346 |
|
| 2011 |
Malki K, Uher R, Paya-Cano J, Binder E, Rietschel M, Zobel A, Mors O, Hauser J, Henigsberg N, Jerman B, Souery D, Placentino A, Ng MY, Cohen-Woods S, Sluyter F, ... ... Aitchison KJ, et al. Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants. Biological Psychiatry. 69: 360-5. PMID 20970119 DOI: 10.1016/J.Biopsych.2010.08.011 |
0.359 |
|
| 2011 |
Keers R, Bonvicini C, Scassellati C, Uher R, Placentino A, Giovannini C, Rietschel M, Henigsberg N, Kozel D, Mors O, Maier W, Hauser J, Souery D, Mendlewicz J, Schmäl C, ... ... Aitchison KJ, et al. Variation in GNB3 predicts response and adverse reactions to antidepressants. Journal of Psychopharmacology (Oxford, England). 25: 867-74. PMID 20826553 DOI: 10.1177/0269881110376683 |
0.399 |
|
| 2011 |
Keers R, Uher R, Huezo-Diaz P, Smith R, Jaffee S, Rietschel M, Henigsberg N, Kozel D, Mors O, Maier W, Zobel A, Hauser J, Souery D, Placentino A, Larsen ER, ... ... Aitchison KJ, et al. Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project. The Pharmacogenomics Journal. 11: 138-45. PMID 20212518 DOI: 10.1038/Tpj.2010.14 |
0.37 |
|
| 2011 |
Rucker J, Aitchison K, Cohen-Woods S, Lewis C, Uher R, Craddock M, Owen M, Muglia P, Breen G, McGuffin P. P.1.034 Copy number variants in CYP450 psychotropic drug metabolising enzymes in a large study of recurrent depressive disorder European Neuropsychopharmacology. 21: S28. DOI: 10.1016/S0924-977X(11)70033-5 |
0.338 |
|
| 2010 |
Drago A, Serretti A, Smith R, Huezo-Diaz P, Malitas P, Albani D, Ronchi DD, Pae CU, Aitchison KJ. No association between genetic markers in BDNF gene and lithium prophylaxis in a Greek sample. International Journal of Psychiatry in Clinical Practice. 14: 154-7. PMID 24922477 DOI: 10.3109/13651501003706717 |
0.349 |
|
| 2010 |
Keers R, Aitchison KJ. Gender differences in antidepressant drug response. International Review of Psychiatry (Abingdon, England). 22: 485-500. PMID 21047161 DOI: 10.3109/09540261.2010.496448 |
0.305 |
|
| 2010 |
Keers R, Uher R, Gupta B, Rietschel M, Schulze TG, Hauser J, Skibinska M, Henigsberg N, Kalember P, Maier W, Zobel A, Mors O, Kristensen AS, Kozel D, Giovannini C, ... ... Aitchison KJ, et al. Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP. Journal of Affective Disorders. 127: 337-42. PMID 20609482 DOI: 10.1016/J.Jad.2010.06.011 |
0.322 |
|
| 2010 |
Lewis CM, Ng MY, Butler AW, Cohen-Woods S, Uher R, Pirlo K, Weale ME, Schosser A, Paredes UM, Rivera M, Craddock N, Owen MJ, Jones L, Jones I, Korszun A, ... Aitchison KJ, et al. Genome-wide association study of major recurrent depression in the U.K. population. The American Journal of Psychiatry. 167: 949-57. PMID 20516156 DOI: 10.1176/Appi.Ajp.2010.09091380 |
0.37 |
|
| 2010 |
McGuffin P, Perroud N, Uher R, Butler A, Aitchison KJ, Craig I, Lewis C, Farmer A. The genetics of affective disorder and suicide. European Psychiatry : the Journal of the Association of European Psychiatrists. 25: 275-7. PMID 20462744 DOI: 10.1016/J.Eurpsy.2009.12.012 |
0.311 |
|
| 2010 |
Uher R, Perroud N, Ng MY, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Zagar T, Czerski PM, Jerman B, Larsen ER, Schulze TG, ... ... Aitchison KJ, et al. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. The American Journal of Psychiatry. 167: 555-64. PMID 20360315 DOI: 10.1176/Appi.Ajp.2009.09070932 |
0.397 |
|
| 2010 |
Su KP, Huang SY, Peng CY, Lai HC, Huang CL, Chen YC, Aitchison KJ, Pariante CM. Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biological Psychiatry. 67: 550-7. PMID 20034614 DOI: 10.1016/J.Biopsych.2009.11.005 |
0.35 |
|
| 2010 |
Uher R, Muthén B, Souery D, Mors O, Jaracz J, Placentino A, Petrovic A, Zobel A, Henigsberg N, Rietschel M, Aitchison KJ, Farmer A, McGuffin P. Trajectories of change in depression severity during treatment with antidepressants. Psychological Medicine. 40: 1367-77. PMID 19863842 DOI: 10.1017/S0033291709991528 |
0.334 |
|
| 2010 |
Perroud N, Uher R, Hauser J, Rietschel M, Henigsberg N, Placentino A, Kozel D, Maier W, Mors O, Souery D, Dmitrzak-Weglarz M, Jorgensen L, Kovacic Z, Giovannini C, Mendlewicz J, ... ... Aitchison KJ, et al. History of suicide attempts among patients with depression in the GENDEP project. Journal of Affective Disorders. 123: 131-7. PMID 19772940 DOI: 10.1016/J.Jad.2009.09.001 |
0.337 |
|
| 2010 |
Aitchison KJ. Clinical lessons from GENDEP for the treatment of depression Annals of General Psychiatry. 9. DOI: 10.1186/1744-859X-9-S1-S6 |
0.324 |
|
| 2009 |
Perroud N, Uher R, Marusic A, Rietschel M, Mors O, Henigsberg N, Hauser J, Maier W, Souery D, Placentino A, Szczepankiewicz A, Jorgensen L, Strohmaier J, Zobel A, Giovannini C, ... ... Aitchison KJ, et al. Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial. Bmc Medicine. 7: 60. PMID 19832967 DOI: 10.1186/1741-7015-7-60 |
0.302 |
|
| 2009 |
Perroud N, Aitchison KJ, Uher R, Smith R, Huezo-Diaz P, Marusic A, Maier W, Mors O, Placentino A, Henigsberg N, Rietschel M, Hauser J, Souery D, Kapelski P, Bonvicini C, et al. Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2517-28. PMID 19641488 DOI: 10.1038/Npp.2009.81 |
0.385 |
|
| 2009 |
Huezo-Diaz P, Uher R, Smith R, Rietschel M, Henigsberg N, Marusic A, Mors O, Maier W, Hauser J, Souery D, Placentino A, Zobel A, Larsen ER, Czerski PM, Gupta B, ... ... Aitchison KJ, et al. Moderation of antidepressant response by the serotonin transporter gene. The British Journal of Psychiatry : the Journal of Mental Science. 195: 30-8. PMID 19567893 DOI: 10.1192/Bjp.Bp.108.062521 |
0.385 |
|
| 2009 |
Uher R, Huezo-Diaz P, Perroud N, Smith R, Rietschel M, Mors O, Hauser J, Maier W, Kozel D, Henigsberg N, Barreto M, Placentino A, Dernovsek MZ, Schulze TG, Kalember P, ... ... Aitchison KJ, et al. Genetic predictors of response to antidepressants in the GENDEP project. The Pharmacogenomics Journal. 9: 225-33. PMID 19365399 DOI: 10.1038/Tpj.2009.12 |
0.411 |
|
| 2009 |
Uher R, Maier W, Hauser J, Marusic A, Schmael C, Mors O, Henigsberg N, Souery D, Placentino A, Rietschel M, Zobel A, Dmitrzak-Weglarz M, Petrovic A, Jorgensen L, Kalember P, ... ... Aitchison KJ, et al. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. The British Journal of Psychiatry : the Journal of Mental Science. 194: 252-9. PMID 19252156 DOI: 10.1192/Bjp.Bp.108.057554 |
0.315 |
|
| 2009 |
Keers R, Farmer AE, Aitchison KJ. Extracting a needle from a haystack: reanalysis of whole genome data reveals a readily translatable finding. Psychological Medicine. 39: 1231-5. PMID 19215628 DOI: 10.1017/S0033291708005084 |
0.326 |
|
| 2009 |
Bull SJ, Huezo-Diaz P, Binder EB, Cubells JF, Ranjith G, Maddock C, Miyazaki C, Alexander N, Hotopf M, Cleare AJ, Norris S, Cassidy E, Aitchison KJ, Miller AH, Pariante CM. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Molecular Psychiatry. 14: 1095-104. PMID 18458677 DOI: 10.1038/Mp.2008.48 |
0.341 |
|
| 2008 |
Forti MD, Morgan C, Mondelli V, Gittens L, Russo M, Handley R, Marquez T, Masson S, Prescott C, Hepgul N, Wiffen B, Pariante C, Aitchison K, Dazzan P, Powell J, et al. Patients With First Episode Psychosis Take More And Stronger Cannabis Than Controls: The Genetics And Psychosis (Gap) Study Schizophrenia Research. 102: 247. DOI: 10.1016/S0920-9964(08)70744-8 |
0.3 |
|
| 2008 |
Tsapakis E, Sugden K, Kinirons M, Scully P, Quinn J, Wright P, Smith S, Murray R, Daly A, Gill M, Waddington J, Kerwin R, Aitchison K. Association Between Alpha2-Receptor Variants And Movement Disorders Schizophrenia Research. 102: 192. DOI: 10.1016/S0920-9964(08)70582-6 |
0.468 |
|
| 2007 |
Su KP, Peng CY, Liao KF, Lai HC, Huang CL, Cheng JC, Aitchison K, Pariante C. P.2.b.005 Polymorphisms in cytosolic phospholipase A2 and cyclooxygenase 2 genes and risk of interferon-induced depression European Neuropsychopharmacology. 17. DOI: 10.1016/S0924-977X(07)70482-0 |
0.335 |
|
| 2006 |
Carboni L, Piubelli C, Vighini M, Khoury AE, Gruber S, Anderssen W, Mathé AA, Aitchison KJ, Mallei A, Giambelli R, Popoli M, Domenici E. P.2.d.007 Proteomic analysis of hippocampus and frontal cortex in a rat model of depression with gene-environment interaction and antidepressant treatment European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)70378-9 |
0.306 |
|
| 2005 |
Huezo-Diaz P, Tandon K, Aitchison KJ. The genetics of depression and related traits. Current Psychiatry Reports. 7: 117-24. PMID 15802088 DOI: 10.1007/S11920-005-0008-5 |
0.341 |
|
| 2005 |
Aitchison KJ, Basu A, McGuffin P, Craig I. Psychiatry and the 'new genetics': hunting for genes for behaviour and drug response. The British Journal of Psychiatry : the Journal of Mental Science. 186: 91-2. PMID 15684228 DOI: 10.1192/Bjp.186.2.91 |
0.317 |
|
| 2005 |
Basu A, Aitchison KJ. Pharmacogenetics: antidepressant drug response Psychiatry. 4: 30-34. DOI: 10.1383/Psyt.2005.4.12.30 |
0.382 |
|
| 2005 |
Tsapakis E, Checkley S, Kerwin R, Aitchison K. P.1.32 Association between the serotonin transporter linked polymorphic region gene and response to tricyclic antidepressants European Neuropsychopharmacology. 15: S26-S27. DOI: 10.1016/S0924-977X(05)80137-3 |
0.541 |
|
| 2004 |
Basu A, Tsapakis E, Aitchison K. Pharmacogenetics and psychiatry. Current Psychiatry Reports. 6: 134-142. PMID 15038916 DOI: 10.1007/S11920-004-0053-5 |
0.31 |
|
| 2004 |
Tsapakis EM, Basu A, Aitchison KJ. Clinical relevance of discoveries in psychopharmacogenetics Advances in Psychiatric Treatment. 10: 455-465. DOI: 10.1192/Apt.10.6.455 |
0.309 |
|
| 2003 |
Tsapakis E, Checkley S, Kerwin R, Aitchison K. P.1.178 Association between the serotonin transporter linked polymorphic region gene (5-HTTLPR) and response to tricyclic antidepressants (TCAs) European Neuropsychopharmacology. 13: S250. DOI: 10.1016/S0924-977X(03)91888-8 |
0.542 |
|
| 2002 |
Tandon K, Schalkwyk L, Patel M, Kinirons M, Kerwin R, McGuffin P, Aitchison K. An amino acid substitution (Ile109Val) in CYP2D6 European Neuropsychopharmacology. 12: 405. DOI: 10.1016/S0924-977X(02)80692-7 |
0.416 |
|
| 2002 |
Aitchison K, Tandon K, Ashworth A, Kerwin R, McGuffin P. Pharmacogenetic studies of tricyclic antidepressant response and an association study of a noradrenaline transporter variant in depression European Neuropsychopharmacology. 12: 92-93. DOI: 10.1016/S0924-977X(02)80022-0 |
0.526 |
|
| 2001 |
Aitchison KJ, Zhao JH, Munro J, Collier DA, Makoff AJ, Kerwin RW. Investigation of an association between a CYP1A2 5′ flanking SNP (T-3591G) and response to clozapine American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 582. |
0.432 |
|
| 2000 |
Aitchison KJ, Jann MW, Zhao JH, Sakai T, Zaher H, Wolff K, Collier DA, Kerwin RW, Gonzalez FJ. Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice. Journal of Psychopharmacology (Oxford, England). 14: 353-9. PMID 11198052 DOI: 10.1177/026988110001400403 |
0.457 |
|
| 2000 |
Aitchison KJ, Gonzalez FJ, Quattrochi LC, Sapone A, Zhao JH, Zaher H, Elizondo G, Bryant C, Munro J, Collier DA, Makoffa AI, Kerwin RW. Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance. Pharmacogenetics. 10: 695-704. PMID 11186132 DOI: 10.1097/00008571-200011000-00004 |
0.485 |
|
| 2000 |
Aitchison KJ, Jordan BD, Sharma T. The relevance of ethnic influences on pharmacogenetics to the treatment of psychosis. Drug Metabolism and Drug Interactions. 16: 15-38. PMID 10820581 DOI: 10.1515/Dmdi.2000.16.1.15 |
0.302 |
|
| 2000 |
Makoff AJ, Graham JM, Arranz MJ, Forsyth J, Li T, Aitchison KJ, Shaikh S, Grünewald RA. Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease. Pharmacogenetics. 10: 43-8. PMID 10739171 DOI: 10.1097/00008571-200002000-00006 |
0.556 |
|
| 2000 |
Aitchison K, Jann M, Wolff K, Sakai T, Makoff A, Collier D, Gonzalez F, Kerwin R. Clozapine pharmacokinetics studied with CYP1A2 knockout mice Schizophrenia Research. 41: 235. DOI: 10.1016/S0920-9964(00)90889-2 |
0.44 |
|
| 1999 |
Aitchison KJ, Munro J, Wright P, Smith S, Makoff AJ, Sachse C, Sham PC, Murray RM, Collier DA, Kerwin RW. Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation. British Journal of Clinical Pharmacology. 48: 388-94. PMID 10510151 DOI: 10.1046/J.1365-2125.1999.00006.X |
0.535 |
|
| 1999 |
Li T, Liu X, Sham PC, Aitchison KJ, Cai G, Arranz MJ, Deng H, Liu J, Kirov G, Murray RM, Collier DA. Association analysis between dopamine receptor genes and bipolar affective disorder. Psychiatry Research. 86: 193-201. PMID 10482338 DOI: 10.1016/S0165-1781(99)00034-7 |
0.574 |
|
| 1998 |
Li T, Arranz M, Aitchison KJ, Bryant C, Liu X, Kerwin RW, Murray R, Sham P, Collier DA. Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia. Schizophrenia Research. 32: 87-92. PMID 9713903 DOI: 10.1016/S0920-9964(98)00024-3 |
0.655 |
|
| 1998 |
Holmes C, Russ C, Kirov G, Aitchison KJ, Powell JF, Collier DA, Lovestone S. Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's disease. Biological Psychiatry. 43: 159-64. PMID 9494696 DOI: 10.1016/S0006-3223(97)00326-0 |
0.33 |
|
| 1997 |
Kerwin RW, Aitchison KJ. Cost-effectiveness of clozapine. The British Journal of Psychiatry : the Journal of Mental Science. 171: 584. PMID 9519106 |
0.368 |
|
| 1997 |
Aitchison KJ, Kerwin RW. Cost-effectiveness of clozapine. A UK clinic-based study. The British Journal of Psychiatry : the Journal of Mental Science. 171: 125-30. PMID 9337946 DOI: 10.1192/Bjp.171.2.125 |
0.479 |
|
| 1997 |
Kunugi H, Vallada HP, Hoda F, Kirov G, Gill M, Aitchison KJ, Ball D, Arranz MJ, Murray RM, Collier DA. No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene. Biological Psychiatry. 42: 282-5. PMID 9270905 DOI: 10.1016/S0006-3223(96)00366-6 |
0.565 |
|
| 1997 |
Sodhi MS, Kirov G, Aitchison KJ, Arranz MJ, Collier DA, Kerwin RW. Allelic variation of the 5-HT2C receptor in psychosis Schizophrenia Research. 24: 90-91. DOI: 10.1016/S0920-9964(97)82246-3 |
0.621 |
|
| 1997 |
Aitchison KJ, Munro J, Wright P, Chapman S, Collier DA, Kerwin RW. Pharmacogenetic factors in treatment-resistant schizophrenia: The role of CYP2D6 variants Schizophrenia Research. 24: 89. DOI: 10.1016/S0920-9964(97)82242-6 |
0.493 |
|
| 1996 |
Hoda F, Nicholl D, Bennett P, Arranz M, Aitchison KJ, al-Chalabi A, Kunugi H, Vallada H, Leigh PN, Chaudhuri KR, Collier DA. No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase. Biochemical and Biophysical Research Communications. 228: 780-4. PMID 8941353 DOI: 10.1006/Bbrc.1996.1731 |
0.549 |
|
| 1996 |
Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gill P, Aitchison KJ, Sodhi M, Li T, Roberts GW, Smith B, Morton J, Murray RM, Smith D, Kirov G. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport. 7: 1675-9. PMID 8904780 DOI: 10.1097/00001756-199607080-00030 |
0.686 |
|
| 1996 |
Shaikh S, Collier DA, Sham PC, Ball D, Aitchison K, Vallada H, Smith I, Gill M, Kerwin RW. Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. Human Genetics. 97: 714-9. PMID 8641685 DOI: 10.1007/Bf02346178 |
0.57 |
|
| 1996 |
Kerwin R, Aitchison K. Cost-effectiveness of treatments for schizophrenia European Neuropsychopharmacology. 6: S4-54. DOI: 10.1016/0924-977X(96)82924-5 |
0.422 |
|
| 1996 |
Aitchison K, Kerwin R. The pharmaco-economics of schizophrenia: New horizons European Psychiatry. 11: 225s. DOI: 10.1016/0924-9338(96)88668-8 |
0.403 |
|
| 1996 |
Sodhi M, Kirov G, Arranz M, Ball D, Aitchison K, Kerwin R, Collier D. Association between psychoses and allelic variation in the 5-HT2C receptor gene Schizophrenia Research. 18: 164. DOI: 10.1016/0920-9964(96)85524-1 |
0.642 |
|
| 1996 |
Shaikh S, Collier D, Sham P, Aitchison K, Ball D, Gill M, Kerwin R. Allelic association between a ser-9-gly polymorphism in the D3 receptor gene and schizophrenia Schizophrenia Research. 18: 163. DOI: 10.1016/0920-9964(96)85520-4 |
0.547 |
|
| 1996 |
Aitchison K, Patel M, Taylor M, Murray R, Arranz M, Collier D, Kerwin R. Neuroleptic sensitivity and enzyme deficiency in two schizophrenic brothers: A case report Schizophrenia Research. 18: 152. DOI: 10.1016/0920-9964(96)85496-X |
0.441 |
|
| 1996 |
Sodhi MS, Arranz MJ, Kirov G, Ball DM, Aitchison KJ, Abusaad I, Kerwin RW, Collier DA. Association between psychoses and allelic variation in 5-HT2A and 5-HT2C receptor genes British Journal of Clinical Pharmacology. 41: 457P. |
0.627 |
|
| 1995 |
Arranz MJ, Dawson E, Shaikh S, Sham P, Sharma T, Aitchison K, Crocq MA, Gill M, Kerwin R, Collier DA. Cytochrome P4502D6 genotype does not determine response to clozapine. British Journal of Clinical Pharmacology. 39: 417-20. PMID 7640149 DOI: 10.1111/J.1365-2125.1995.Tb04471.X |
0.65 |
|
| 1995 |
Aitchison K, Kerwin R. The costs and benefits of clozapine therapy in the UK Schizophrenia Research. 15: 141. DOI: 10.1016/0920-9964(95)95436-D |
0.358 |
|
| 1995 |
Arranz M, Aitchison K, Kerwin R, Collier D. Analyses of clozapine response and the 5-HT2 gene Schizophrenia Research. 15: 35. DOI: 10.1016/0920-9964(95)95114-O |
0.473 |
|
| 1995 |
Arranz MJ, Dawson E, Shaikh S, Sharma T, Aitchison K, Crog MA, Gill M, Kerwin R, Collier DA. Cytochrome P450IID6 genotype does not determine response to clozapine Schizophrenia Research. 15: 35. DOI: 10.1016/0920-9964(95)95112-M |
0.51 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2008 |
Uher R, Farmer A, Maier W, Rietschel M, Hauser J, Marusic A, Mors O, Elkin A, Williamson RJ, Schmael C, Henigsberg N, Perez J, Mendlewicz J, Janzing JG, Zobel A, ... ... Aitchison KJ, et al. Measuring depression: comparison and integration of three scales in the GENDEP study. Psychological Medicine. 38: 289-300. PMID 17922940 DOI: 10.1017/S0033291707001730 |
0.298 |
|
| 2011 |
Binder E, Malki K, Paya-Cano JL, Fernandes C, Aitchison KJ, Mathé AA, Sluyter F, Schalkwyk LC. Antidepressants and the resilience to early-life stress in inbred mouse strains. Pharmacogenetics and Genomics. 21: 779-89. PMID 22016050 DOI: 10.1097/Fpc.0B013E32834B3F35 |
0.297 |
|
| 2019 |
Jiang S, Postovit L, Cattaneo A, Binder EB, Aitchison KJ. Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma. Frontiers in Psychiatry. 10: 808. PMID 31780969 DOI: 10.3389/Fpsyt.2019.00808 |
0.296 |
|
| 2012 |
Vyas NS, Shamsi SA, Malhotra AK, Aitchison KJ, Kumari V. Can genetics inform the management of cognitive deficits in schizophrenia? Journal of Psychopharmacology (Oxford, England). 26: 334-48. PMID 22328662 DOI: 10.1177/0269881111434623 |
0.295 |
|
| 2009 |
Uher R, Farmer A, Henigsberg N, Rietschel M, Mors O, Maier W, Kozel D, Hauser J, Souery D, Placentino A, Strohmaier J, Perroud N, Zobel A, Rajewska-Rager A, Dernovsek MZ, ... ... Aitchison KJ, et al. Adverse reactions to antidepressants. The British Journal of Psychiatry : the Journal of Mental Science. 195: 202-10. PMID 19721108 DOI: 10.1192/Bjp.Bp.108.061960 |
0.293 |
|
| 2017 |
Lopez JP, Fiori LM, Cruceanu C, Lin R, Labonte B, Cates HM, Heller EA, Vialou V, Ku SM, Gerald C, Han MH, Foster J, Frey BN, Soares CN, Müller DJ, ... ... Aitchison KJ, et al. MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes. Nature Communications. 8: 15497. PMID 28530238 DOI: 10.1038/Ncomms15497 |
0.293 |
|
| 2008 |
Iyegbe C, Luzi S, Mondelli V, Marques T, Handley R, Seddigh A, Miorelli A, Navari S, Prescott C, Gittens L, Aas M, Hepgul N, Bertani M, Wiffen B, Masson S, ... ... Aitchison K, et al. Polymorphisms In Disc1 Predict The Severity Of Positive Symptoms In A Multi-Ethnic First Episode Cohort Schizophrenia Research. 102: 197. DOI: 10.1016/S0920-9964(08)70595-4 |
0.292 |
|
| 2006 |
Mallei A, Giambelli R, Barbiero VS, Mathe AA, Khoury AE, Carboni L, Domenici E, Aitchison K, Racagni G, Popoli M. S.04.01 Functional proteomic analysis of an animal model of depression combining genetic vulnerability and environmental stress European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)70028-1 |
0.291 |
|
| 2007 |
Aas M, Eyeson J, Mondelli V, Aitchison K, Forti MD, Murray R, Collier D, Dazzan P, Morgan K, Pariante C. P.3.b.002 Does COMT polymorphism influence cognitive function in first episode psychosis European Neuropsychopharmacology. 17. DOI: 10.1016/S0924-977X(07)70085-8 |
0.29 |
|
| 2009 |
Bull S, Heuzo-Diaz P, Binder E, Cubells J, Ranjith G, Maddock C, Hotopf M, Norris S, Cassidy E, Aitchison K, Cleare A, Miller A, Pariante C. 16. IL-10 genetic variants and hepatitis C patients’ symptoms of depression and fatigue before and during Interferon-alpha treatment Brain, Behavior, and Immunity. 23: S29. DOI: 10.1016/J.Bbi.2009.06.021 |
0.29 |
|
| 2020 |
Fan M, Yarema MC, Box A, Hume S, Aitchison KJ, Bousman CA. Identification of high-impact gene-drug pairs for pharmacogenetic testing in Alberta, Canada. Pharmacogenetics and Genomics. PMID 32826605 DOI: 10.1097/Fpc.0000000000000418 |
0.29 |
|
| 2006 |
D'Souza U, Sugden K, Aitchison K, Schalkwyk L, McGuffin P, Pariante M. S.16.02 Depression: the GENDEP study European Neuropsychopharmacology. 16: S187. DOI: 10.1016/S0924-977X(06)70079-7 |
0.289 |
|
| 2010 |
Mondelli V, Dazzan P, Hepgul N, Di Forti M, Aas M, D'Albenzio A, Di Nicola M, Fisher H, Handley R, Marques TR, Morgan C, Navari S, Taylor H, Papadopoulos A, Aitchison KJ, et al. Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment. Schizophrenia Research. 116: 234-42. PMID 19751968 DOI: 10.1016/J.Schres.2009.08.013 |
0.288 |
|
| 2006 |
Huezo-Diaz P, Nash M, Hoda F, Williamson R, McGuffin P, Craig I, Aitchison K. Genetic association data from GENDEP, a multicentre European study European Neuropsychopharmacology. 16: S35-S36. DOI: 10.1016/S0924-977X(06)80044-1 |
0.288 |
|
| 2019 |
Talarico F, Uher R, Farmer A, McGuffin P, Rietschel M, Maier W, Henigsberg N, Hauser J, Cattaneo A, Dernovsek M, Aitchison K. T75Gwas And Pathway Enrichment Analysis In Adverse Drug Reactions In Depression European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.08.274 |
0.287 |
|
| 2014 |
Koola MM, Buchanan RW, Pillai A, Aitchison KJ, Weinberger DR, Aaronson ST, Dickerson FB. Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia. Schizophrenia Research. 157: 84-9. PMID 24878431 DOI: 10.1016/J.Schres.2014.04.037 |
0.285 |
|
| 2011 |
Mondelli V, Cattaneo A, Belvederi Murri M, Di Forti M, Handley R, Hepgul N, Miorelli A, Navari S, Papadopoulos AS, Aitchison KJ, Morgan C, Murray RM, Dazzan P, Pariante CM. Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume. The Journal of Clinical Psychiatry. 72: 1677-84. PMID 21672499 DOI: 10.4088/Jcp.10M06745 |
0.285 |
|
| 2014 |
Crawford A, Lewis S, Hodgson K, McGuffin P, Aitchison K, Nutt D, Peters T, Cowen P, O'Donovan M, Wiles N, Lewis G. P.2.a.021 Genome-wide association study of antidepressant-induced sexual dysfunction in depressed males European Neuropsychopharmacology. 24: S373-S374. DOI: 10.1016/S0924-977X(14)70596-6 |
0.284 |
|
| 2006 |
Forti MD, Butt A, Miorelli A, Gafoor R, Mondelli V, Saeedzadeh-Sardahaee F, Mule A, Aitchison K, Dazzan P, Morgan C, Murray R. Tc2C Use Of Cannabis In A East-London First Episode Psychosis Sample: Data From The Gap — Genetics And Psychosis — Study Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70075-5 |
0.283 |
|
| 2009 |
Uher R, Mors O, Hauser J, Rietschel M, Maier W, Kozel D, Henigsberg N, Souery D, Placentino A, Perroud N, Dernovsek MZ, Strohmaier J, Larsen ER, Zobel A, Leszczynska-Rodziewicz A, ... ... Aitchison KJ, et al. Body weight as a predictor of antidepressant efficacy in the GENDEP project. Journal of Affective Disorders. 118: 147-54. PMID 19269691 DOI: 10.1016/J.Jad.2009.02.013 |
0.283 |
|
| 2004 |
Howes OD, Smith S, Aitchison KJ. Comment on Hyperprolactinaemia and antipsychotic therapy in schizophrenia. Current Medical Research and Opinion. 20: 1649. PMID 15462698 DOI: 10.1185/030079904X4941 |
0.282 |
|
| 1988 |
Aitchison K, Ogilvie D, Honeyman M, Thompson E, Sykes B. Homozygous osteogenesis imperfecta unlinked to collagen I genes. Human Genetics. 78: 233-6. PMID 2894346 DOI: 10.1007/Bf00291667 |
0.28 |
|
| 2010 |
Sugden K, Pariante CM, McGuffin P, Aitchison KJ, D'Souza UM. Housekeeping gene expression is affected by antidepressant treatment in a mouse fibroblast cell line. Journal of Psychopharmacology (Oxford, England). 24: 1253-9. PMID 19074533 DOI: 10.1177/0269881108099690 |
0.279 |
|
| 2017 |
Fabbri C, Tansey K, Perlis R, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Breen G, Curtis C, Sang-Hyuk L, Newhouse S, Patel H, ... ... Aitchison K, et al. Meta-analysis of CYP2C19 association with efficacy and side effects of citalopram and escitalopram European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31117-3 |
0.279 |
|
| 2008 |
Bull S, Pariante C, Huezo-Diaz P, Aitchison K, Cleare A. 90. Functional polymorphisms in the interleukin-6 and IL-10 genes and psychopathological symptoms in patients with chronic fatigue syndrome Brain, Behavior, and Immunity. 22: 28. DOI: 10.1016/J.Bbi.2008.04.091 |
0.278 |
|
| 2006 |
Mathé A, Nikisch G, Agren H, Baumann P, El Khoury A, Gruber S, Husum H, Jiménez-Vasquez P, Wortwein G, Andersson W, Aitchison K, McGuffin P. P.2.b.013 Neuropeptides in human cerebrospinal fluid and in brains of animal models of depression - effects of treatment European Neuropsychopharmacology. 16: S308-S309. DOI: 10.1016/S0924-977X(06)70327-3 |
0.278 |
|
| 2009 |
Di Forti M, Morgan C, Mondelli V, Gittens L, Handley R, Hepgul N, Luzi S, Marques T, Aas M, Masson S, Prescott C, Russo M, Sood P, Wiffen B, Papili P, ... ... Aitchison K, et al. Skunk and psychosis in South East London European Psychiatry. 24: 1-1. DOI: 10.1016/S0924-9338(09)70267-6 |
0.276 |
|
| 2008 |
Prescott C, Forti MD, Mondelli V, Gittens L, Handley R, Taylor H, ShakerNaeeni H, Nayeb L, Hepgul N, Luzi S, Marques T, Aas M, Masson S, Russo M, Sood P, ... ... Aitchison K, et al. The Relationship Between Ethnicity And Psychotic Symptoms As Measured By The Scan: Pilot Data From The Genetics And Psychosis (Gap) Study Schizophrenia Research. 102: 174. DOI: 10.1016/S0920-9964(08)70532-2 |
0.275 |
|
| 2008 |
Wiffen B, Masson S, Aas M, Handley R, Hepgul N, Marques T, Prescott C, Sloane C, Sood P, Taylor H, Seddigh A, DiForti M, Pariante C, Mondelli V, Dazzan P, ... Aitchison K, et al. Differences In Psychopathology With Disrupted Insight In First-Episode Psychosis: The Gap Study Schizophrenia Research. 102: 149. DOI: 10.1016/S0920-9964(08)70451-1 |
0.275 |
|
| 2013 |
Almandil NB, Liu Y, Murray ML, Besag FM, Aitchison KJ, Wong IC. Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis. Paediatric Drugs. 15: 139-50. PMID 23519708 DOI: 10.1007/S40272-013-0016-6 |
0.275 |
|
| 2010 |
Keers R, Ingelman-Sundberg M, Hauser J, Maier W, Rietschel M, Mors O, McGuffin P, Farmer AE, Craig IW, Aitchison KJ. P.3.010 CYP2D6 and CYP2C19 genotypes predict antidepressant dose in the GENDEP project European Neuropsychopharmacology. 20. DOI: 10.1016/S0924-977X(10)70082-1 |
0.275 |
|
| 2008 |
Mir A, Shivakumar K, Williamson RJ, McAllister V, O'Keane V, Aitchison KJ. Change in sexual dysfunction with aripiprazole: a switching or add-on study. Journal of Psychopharmacology (Oxford, England). 22: 244-53. PMID 18308789 DOI: 10.1177/0269881107082901 |
0.274 |
|
| 2007 |
Sugden K, D'Souza U, Aitchison K, Schalkwyk L, McGuffin P, Byers H, Campbell J, Hye A, Pariante C. P.1.31 Gene expression analyses of mouse fibroblast cell line L929 after antidepressant treatment European Neuropsychopharmacology. 17: S27-S28. DOI: 10.1016/S0924-977X(07)70032-9 |
0.269 |
|
| 2018 |
Lodhi R, Wang Y, McIntyre G, Rossolatos D, Sivapalan S, Henriques B, Heywood B, Crocker C, Purdon S, Aitchison K, Tibbo P. F190. EFFECT OF SELECTED GENE VARIANTS ON THE RELATIONSHIP BETWEEN EARLY CANNABIS USE AND AGE OF ONSET OF PSYCHOSIS Schizophrenia Bulletin. 44: S295-S295. DOI: 10.1093/Schbul/Sby017.721 |
0.269 |
|
| 2009 |
Aitchison KJ, Bienroth M, Cookson J, Gray R, Haddad PM, Moore B, Ratna L, Sullivan G, Taylor D, Taylor M, Goodwin GM. A UK consensus on the administration of aripiprazole for the treatment of mania. Journal of Psychopharmacology (Oxford, England). 23: 231-40. PMID 19010974 DOI: 10.1177/0269881108098820 |
0.269 |
|
| 2008 |
Cratsley K, Regan J, Mcallister V, Simic M, Aitchison KJ. Duration of untreated psychosis, referral route, and age of onset in an early intervention in psychosis service and a local CAMHS Child and Adolescent Mental Health. 13: 130-133. DOI: 10.1111/J.1475-3588.2007.00467.X |
0.269 |
|
| 1999 |
Cervilla JA, Russ C, Holmes C, Aitchison K, Smith CA, Powell J, Lovestone S. CYP2D6 polymorphisms in Alzheimer's disease, with and without extrapyramidal signs, showing no apolipoprotein E epsilon 4 effect modification. Biological Psychiatry. 45: 426-9. PMID 10071712 DOI: 10.1016/S0006-3223(98)00060-2 |
0.266 |
|
| 2003 |
Holloway F, Aitchison K. Early intervention in psychosis: from Government prescription to clinical practice Psychiatric Bulletin. 27: 243-244. DOI: 10.1192/Pb.03-115 |
0.265 |
|
| 2009 |
Perroud N, Uher R, Maier W, Mors O, Henigsberg N, Rietschel M, Hauser J, Farmer A, Aitchison K, McGuffin P. P.3.13 Temperament and character of subjects with treatment increase suicidal ideations in the GENDEP study European Neuropsychopharmacology. 19: S72-S73. DOI: 10.1016/S0924-977X(09)70083-5 |
0.262 |
|
| 2006 |
McAllister V, Gaiotto L, Gungadin R, Cratsley K, Mir A, Dazzan P, Aitchison K. 0508 PATHWAYS TO CARE FOR TREATMENT OF YOUNG ADULTS WITH A PSYCHOTIC ILLNESS IN SOUTH LONDON Schizophrenia Research. 86: S126. DOI: 10.1016/S0920-9964(06)70377-2 |
0.261 |
|
| 2008 |
Masson S, Wiffen B, Forti MD, Aas M, Handley R, Hepgul N, Tiago M, Mondelli V, Prescott C, Sloane C, Sood P, Taylor H, Luzi S, Seddigh A, Pariante C, ... ... Aitchison K, et al. Cannabis Use And Symptoms Of Psychosis In First Episode Patients:Gap Study Schizophrenia Research. 102: 249. DOI: 10.1016/S0920-9964(08)70751-5 |
0.261 |
|
| 2011 |
Aas M, Dazzan P, Mondelli V, Toulopoulou T, Reichenberg A, Di Forti M, Fisher HL, Handley R, Hepgul N, Marques T, Miorelli A, Taylor H, Russo M, Wiffen B, Papadopoulos A, ... Aitchison KJ, et al. Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis. Psychological Medicine. 41: 463-76. PMID 20529412 DOI: 10.1017/S0033291710001170 |
0.261 |
|
| 2008 |
Ohlsen RI, Williamson R, Yusufi B, Mullan J, Irving D, Mukherjee S, Page E, Aitchison KJ, Barnes TR. Interrater reliability of the Antipsychotic Non-Neurological Side-Effects Rating Scale measured in patients treated with clozapine. Journal of Psychopharmacology (Oxford, England). 22: 323-9. PMID 18541627 DOI: 10.1177/0269881108091069 |
0.26 |
|
| 2010 |
Mondelli V, Pariante CM, Navari S, Aas M, D'Albenzio A, Di Forti M, Handley R, Hepgul N, Marques TR, Taylor H, Papadopoulos AS, Aitchison KJ, Murray RM, Dazzan P. Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis. Schizophrenia Research. 119: 75-8. PMID 20071148 DOI: 10.1016/J.Schres.2009.12.021 |
0.259 |
|
| 2019 |
Kingston D, Mughal MK, Arshad M, Kovalchuk I, Metz GAS, Wynne-Edwards K, King S, Jiang S, Postovit L, Wajid A, McDonald S, Slater DM, Tough SC, Aitchison K, Arnold P. Prediction and Understanding of Resilience in Albertan Families: Longitudinal Study of Disaster Responses (PURLS) - Protocol. Frontiers in Psychiatry. 10: 729. PMID 31736793 DOI: 10.3389/Fpsyt.2019.00729 |
0.257 |
|
| 2013 |
Dominguez MD, Fisher HL, Major B, Chisholm B, Rahaman N, Joyce J, Woolley J, Lawrence J, Hinton M, Marlowe K, Aitchison K, Johnson S, Hodes M. Duration of untreated psychosis in adolescents: ethnic differences and clinical profiles. Schizophrenia Research. 150: 526-32. PMID 24025696 DOI: 10.1016/J.Schres.2013.08.018 |
0.255 |
|
| 1999 |
Taylor D, Aitchison KJ. The pharmaco-economics of atypical antipsychotics International Journal of Psychiatry in Clinical Practice. 3: 237-248. DOI: 10.3109/13651509909068390 |
0.255 |
|
| 2010 |
Keers R, Ingelman-Sundberg M, Hauser J, Maier W, Rietschel M, Mors O, McGuffin P, Farmer A, Craig I, Aitchison K. S.07.04 CYP2D6 genotype predicts antidepressant dose in the GENDEP project European Neuropsychopharmacology. 20: S172-S173. DOI: 10.1016/S0924-977X(10)70148-6 |
0.255 |
|
| 2014 |
Sivapalan S, Aitchison KJ. Neurological structure variations in individuals with autism spectrum disorder: A review Klinik Psikofarmakoloji Bulteni. 24: 268-275. DOI: 10.5455/Bcp.20140903110206 |
0.254 |
|
| 2011 |
Aitchison KJ, Mir A, Shivakumar K, McAllister VD, O'Keane V, McCrone P. Costs and outcomes associated with an aripiprazole add-on or switching open-label study in psychosis. Journal of Psychopharmacology (Oxford, England). 25: 675-84. PMID 20176773 DOI: 10.1177/0269881109358198 |
0.254 |
|
| 2013 |
Di Nicola M, Cattaneo A, Hepgul N, Di Forti M, Aitchison KJ, Janiri L, Murray RM, Dazzan P, Pariante CM, Mondelli V. Serum and gene expression profile of cytokines in first-episode psychosis. Brain, Behavior, and Immunity. 31: 90-5. PMID 22749891 DOI: 10.1016/J.Bbi.2012.06.010 |
0.25 |
|
| 2011 |
Uher R, Mors O, Hauser J, Rietschel M, Maier W, Kozel D, Henigsberg N, Souery D, Placentino A, Keers R, Gray JM, Dernovsek MZ, Strohmaier J, Larsen ER, Zobel A, ... ... Aitchison KJ, et al. Changes in body weight during pharmacological treatment of depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 367-75. PMID 20716398 DOI: 10.1017/S1461145710000933 |
0.25 |
|
| 2011 |
Masand S, Sherwood R, Aitchison K. An increase in bone stability in an aripiprazole add-on or switching study European Psychiatry. 26: 1257-1257. DOI: 10.1016/S0924-9338(11)72962-5 |
0.25 |
|
| 2006 |
Wolff K, Tsapakis EM, Winstock AR, Hartley D, Holt D, Forsling ML, Aitchison KJ. Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population. Journal of Psychopharmacology (Oxford, England). 20: 400-10. PMID 16574714 DOI: 10.1177/0269881106061514 |
0.244 |
|
| 2013 |
Baldwin DS, Aitchison K, Bateson A, Curran HV, Davies S, Leonard B, Nutt DJ, Stephens DN, Wilson S. Benzodiazepines: risks and benefits. A reconsideration. Journal of Psychopharmacology (Oxford, England). 27: 967-71. PMID 24067791 DOI: 10.1177/0269881113503509 |
0.243 |
|
| 2022 |
Pain O, Hodgson K, Trubetskoy V, Ripke S, Marshe VS, Adams MJ, Byrne EM, Campos AI, Carrillo-Roa T, Cattaneo A, Als TD, Souery D, Dernovsek MZ, Fabbri C, Hayward C, ... ... Aitchison KJ, et al. Identifying the Common Genetic Basis of Antidepressant Response. Biological Psychiatry Global Open Science. 2: 115-126. PMID 35712048 DOI: 10.1016/j.bpsgos.2021.07.008 |
0.241 |
|
| 2016 |
Lodhi RJ, Masand S, Malik A, Shivakumar K, McAllister VD, O'Keane V, Young LC, Heald AH, Sherwood RA, Aitchison KJ. Changes in biomarkers of bone turnover in an aripiprazole add-on or switching study. Schizophrenia Research. PMID 26792297 DOI: 10.1016/J.Schres.2015.12.007 |
0.239 |
|
| 2008 |
Fisher H, Theodore K, Power P, Chisholm B, Fuller J, Marlowe K, Aitchison KJ, Tanna R, Joyce J, Sacks M, Craig T, Johnson S. Routine evaluation in first episode psychosis services: feasibility and results from the MiData project. Social Psychiatry and Psychiatric Epidemiology. 43: 960-7. PMID 18560782 DOI: 10.1007/S00127-008-0386-1 |
0.237 |
|
| 2010 |
Cattaneo A, Mondelli V, Dazzan P, Murri MB, Forti MD, Ohlsen R, Gennarelli M, Aitchison KJ, Murray RM, Pariante CM. Inflammatory and neurotrophic factors unbalance in leukocytes of first episode psychosis patients Brain Behavior and Immunity. 24. DOI: 10.1016/J.Bbi.2010.07.106 |
0.236 |
|
| 2020 |
Tibbo PG, McKee KA, Meyer JH, Crocker CE, Aitchison KJ, Lam RW, Crockford DN. Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness? Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720945525. PMID 32911977 DOI: 10.1177/0706743720945525 |
0.233 |
|
| 2013 |
Ghali S, Fisher HL, Joyce J, Major B, Hobbs L, Soni S, Chisholm B, Rahaman N, Papada P, Lawrence J, Bloy S, Marlowe K, Aitchison KJ, Power P, Johnson S. Ethnic variations in pathways into early intervention services for psychosis. The British Journal of Psychiatry : the Journal of Mental Science. 202: 277-83. PMID 22955006 DOI: 10.1192/Bjp.Bp.111.097865 |
0.233 |
|
| 2010 |
Basu A, Sugden K, Tandon K, Fernandes C, Tsapakis E, Stephenson J, Aitchison K. P.1.001 Chronic clozapine treatment reduces reelin expression in the rat prefrontal cortex European Neuropsychopharmacology. 20: S2-S3. DOI: 10.1016/S0924-977X(10)70004-3 |
0.23 |
|
| 2003 |
Tandon K, Kinirons M, Patel M, McGuffin P, Aitchison K. P.6.033 Decline in CYP2D6 metabolising capacity in the elderly European Neuropsychopharmacology. 13: S439-S440. DOI: 10.1016/S0924-977X(03)92332-7 |
0.23 |
|
| 2006 |
Tsapakis E, Wolff K, Winstock A, Huezo-Diaz P, Pariante C, Hartley D, Holt D, Forsling M, Aitchison K. CYP2D6 variants and ecstasy-induced changes in neurohypophysial hormones European Neuropsychopharmacology. 16: S33. DOI: 10.1016/S0924-977X(06)80041-6 |
0.228 |
|
| 2005 |
Howes OD, Smith S, Aitchison KJ. Comments on "Prolactin levels and erectile function in patients treated with risperidone" (J Clin Psychopharmacol 2004;24:161-166). Journal of Clinical Psychopharmacology. 25: 393-4. PMID 16012288 DOI: 10.1097/01.Jcp.0000170033.78060.84 |
0.226 |
|
| 2010 |
Mondelli V, Aas M, Murri MB, Forti MD, Fisher H, Handley R, Hepgul N, Marques TR, Morgan C, Taylor H, Aitchison KJ, Dazzan P, Murray RM, Pariante CM. Does Stress Contribute To Inflammatory And Metabolic Abnormalities In First Episode Psychosis Schizophrenia Research. 117: 369-370. DOI: 10.1016/J.Schres.2010.02.658 |
0.226 |
|
| 2010 |
Aitchison K, Datla K, Rooprai H, Fernando J, Dexter D. Regional distribution of clomipramine and desmethylclomipramine in rat brain and peripheral organs on chronic clomipramine administration. Journal of Psychopharmacology (Oxford, England). 24: 1261-8. PMID 19553387 DOI: 10.1177/0269881109105789 |
0.224 |
|
| 2008 |
Gittens L, Forti MD, Morgan C, Fisher H, Mondelli V, Handley R, Hepgul N, Luzi S, Tiago M, Aas M, Masson S, Prescott C, Russo M, Sood P, Wiffen B, ... ... Aitchison K, et al. Markers Of Social Isolation And Cannabis Use In A South East London First Episode Psychosis Sample Schizophrenia Research. 102: 172. DOI: 10.1016/S0920-9964(08)70526-7 |
0.22 |
|
| 2014 |
Gassó P, Pagerols M, Flamarique I, Castro-Fornieles J, Rodriguez N, Mas S, Curran S, Aitchison K, Santosh P, Lafuente A. The effect of age on DNA concentration from whole saliva: implications for the standard isolation method. American Journal of Human Biology : the Official Journal of the Human Biology Council. 26: 859-62. PMID 25065578 DOI: 10.1002/Ajhb.22593 |
0.217 |
|
| 2008 |
Goyder J, Gaiotto L, McAllister V, Aitchison K, Dazzan P, Bristow F, McCrone P. HOSPITAL ADMISSION AMONGST PATIENTS PRESENTING WITH FIRST EPISODE PSYCHOSIS IN CROYDON, SOUTH LONDON Schizophrenia Research. 102: 162. DOI: 10.1016/S0920-9964(08)70492-4 |
0.216 |
|
| 2006 |
Shivakumar K, Mir A, McAllister V, O'Keane V, McCrone P, Holloway F, Aitchison K. 0515 Aripiprazole Switching Strategies In Community Patients With Psychosis Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70401-7 |
0.215 |
|
| 2006 |
Gaiotto L, McAllister V, Bristow F, McCrone P, Aitchison K. 0512 PATHWAYS INTO CARE FOR A FIRST EPISODE OF A PSYCHOTIC ILLNESS IN CROYDON, SOUTH LONDON Schizophrenia Research. 86: S126. DOI: 10.1016/S0920-9964(06)70378-4 |
0.213 |
|
| 2021 |
Carvalho Henriques B, Buchner A, Hu X, Wang Y, Yavorskyy V, Wallace K, Dong R, Martens K, Carr MS, Behroozi Asl B, Hague J, Sivapalan S, Maier W, Dernovsek MZ, Henigsberg N, ... ... Aitchison KJ, et al. Methodology for clinical genotyping of CYP2D6 and CYP2C19. Translational Psychiatry. 11: 596. PMID 34811360 DOI: 10.1038/s41398-021-01717-9 |
0.208 |
|
| 2014 |
Rossolatos D, Aitchison KJ. Genomics for clinical utility: the future is near. Genome Medicine. 6: 3. PMID 24468134 DOI: 10.1186/Gm522 |
0.207 |
|
| 2020 |
Aitchison K, Henriques BC, Yavorskyy V, Wang Y, Martens K, Asl BB, Carr M, Hague J, Hu X, Maier W, Dernovsek MZ, Henigsberg N, Souery D, Cattaneo A, Mors O, et al. CYP2D6 Revisited in GENDEP: Inter-Platform Concordance Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.393 |
0.205 |
|
| 2023 |
Li D, Pain O, Fabbri C, Wong WLE, Lo CWH, Ripke S, Cattaneo A, Souery D, Dernovsek MZ, Henigsberg N, Hauser J, Lewis G, Mors O, Perroud N, Rietschel M, ... ... Aitchison KJ, et al. Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies. Medrxiv : the Preprint Server For Health Sciences. PMID 37425775 DOI: 10.1101/2023.06.26.23291890 |
0.205 |
|
| 2009 |
Aitchison K, Serretti A, Goldman D, Curran S, Drago A, Malhotra AK. The 8th annual pharmacogenetics in psychiatry meeting report Pharmacogenomics Journal. 9: 358-361. PMID 19841640 DOI: 10.1038/Tpj.2009.47 |
0.205 |
|
| 2020 |
Maruf AA, Fan M, Arnold PD, Müller DJ, Aitchison KJ, Bousman CA. Pharmacogenetic Testing Options Relevant to Psychiatry in Canada. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720904820. PMID 32064906 DOI: 10.1177/0706743720904820 |
0.204 |
|
| 2024 |
Thamilselvan M, Mather C, Wang Y, Foo JC, Aitchison KJ. Haplotype phasing of CYP2D6: an allelic ratio method using Agena MassARRAY data. Translational Psychiatry. 14: 91. PMID 38346976 DOI: 10.1038/s41398-024-02809-y |
0.202 |
|
| 2007 |
Maitland-van der Zee AH, Aitchison K, Kirchheiner J. Workshop outcomes report: initiatives to establish a European Network of pharmacogenetics/genomics and progress. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 31: 151-5. PMID 17452095 DOI: 10.1016/J.Ejps.2007.03.009 |
0.201 |
|
| 2014 |
Zhang JP, Aitchison KJ, Malhotra AK. The 12th Annual Pharmacogenetics in Psychiatry meeting report. Psychiatric Genetics. 24: 218-20. PMID 24859420 DOI: 10.1097/Ypg.0000000000000041 |
0.201 |
|
| 2008 |
Tandon K, Aitchison KJ. Genetic Approaches to Depression: Association Studies Biology of Depression: From Novel Insights to Therapeutic Strategies. 757-795. DOI: 10.1002/9783527619672.ch31 |
0.197 |
|
| 2011 |
Wolff K, Tsapakis E, Forsling M, Aitchison K. S.23.03 Effects of ecstasy consumption on water homeostasis and secretion of vasopressin and oxytocin: a pharmacogenetic study European Neuropsychopharmacology. 21: S222-S223. DOI: 10.1016/S0924-977X(11)70333-9 |
0.195 |
|
| 2006 |
Mir A, Shivakumar K, McAllister V, Holloway F, O'Keane V, McCrone P, Aitchison K. 0510 CHANGE IN SEXUAL DYSFUNCTION ON SWITCHING TO ARIPIPRAZOLE Schizophrenia Research. 86: S134. DOI: 10.1016/S0920-9964(06)70400-5 |
0.192 |
|
| 2019 |
Aitchison K, Lodhi RJ, Wang Y, Henriques BC, Hu X, Lee D, Lapetina DL, Hauser J, Maier W, Dernovsek MZ, Henigsberg N, Souery D, Cattaneo A, Mors O, Rietschel M, et al. F93. CYP2D6 Revisited in GENDEP, a Multicenter Clinical Trial of Nortriptyline and Escitalopram Biological Psychiatry. 85: S248-S249. DOI: 10.1016/J.Biopsych.2019.03.630 |
0.189 |
|
| 2018 |
Tibbo P, Cracker CE, Lam RW, Meyer J, Sareen J, Aitchison KJ. Implications of Cannabis Legalization on Youth and Young Adults. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 63: 65-71. PMID 29364696 DOI: 10.1177/0706743718759031 |
0.186 |
|
| 2015 |
Rooprai HK, Ashkan K, Brazil L, Selway RP, Lodhi R, Aitchison KJ, Gullan RW, Beaney R. Role of a Combination of Seven Micronutrients in the Management of Glioblastoma Multiforme. Clinical Oncology (Royal College of Radiologists (Great Britain)). 27: 370-1. PMID 25681869 DOI: 10.1016/J.Clon.2015.01.010 |
0.184 |
|
| 2013 |
Wolff K, Aitchison KJ. Reply to 'MDMA can increase cortical levels by 800% in dance clubbers' Parrott et al Journal of Psychopharmacology. 27: 115-116. PMID 23255437 DOI: 10.1177/0269881112455288 |
0.183 |
|
| 2023 |
Vreijling SR, Chin Fatt CR, Williams LM, Schatzberg AF, Usherwood T, Nemeroff CB, Rush AJ, Uher R, Aitchison KJ, Köhler-Forsberg O, Rietschel M, Trivedi MH, Jha MK, Penninx BWJH, Beekman ATF, et al. Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials. The British Journal of Psychiatry : the Journal of Mental Science. 1-9. PMID 38130122 DOI: 10.1192/bjp.2023.148 |
0.176 |
|
| 2018 |
Almandil NB, Lodhi RJ, Ren H, Besag FMC, Rossolatos D, Ohlsen R, Slomp C, Lapetina DL, Plazzotta G, Murray ML, Al-Sulaiman AA, Gringras P, Wong ICK, Aitchison KJ. Associations between the -2548G/A Promoter and Baseline Weight and between Gln223Arg and Lys656Asn Variants and Change in BMI Scores in Arab Children and Adolescents Treated with Risperidone. Molecular Neuropsychiatry. 4: 111-117. PMID 30397599 DOI: 10.1159/000490463 |
0.175 |
|
| 2020 |
Al Maruf A, Fan M, Arnold PD, Müller DJ, Aitchison K, Bousman CA. Reply to Dawes et al. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720925736. PMID 32425056 DOI: 10.1177/0706743720925736 |
0.172 |
|
| 2012 |
Aitchison KJ, Reynolds GP. Special issue on Pharmacogenetics. Journal of Psychopharmacology (Oxford, England). 26: 333. PMID 22378768 DOI: 10.1177/0269881112439150 |
0.169 |
|
| 2020 |
Maruf AA, Stein K, Arnold PD, Aitchison KJ, Müller DJ, Bousman C. and Antipsychotic Treatment Outcomes in Children and Youth: A Systematic Review. Journal of Child and Adolescent Psychopharmacology. PMID 33074724 DOI: 10.1089/cap.2020.0093 |
0.168 |
|
| 2020 |
Carvalho Henriques B, Yang EH, Lapetina D, Carr MS, Yavorskyy V, Hague J, Aitchison KJ. How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing? Frontiers in Genetics. 11: 491895. PMID 33363564 DOI: 10.3389/fgene.2020.491895 |
0.168 |
|
| 2021 |
Köhler-Forsberg O, Keers R, Uher R, Hauser J, Maier W, Rietschel M, McGuffin P, Farmer AE, Aitchison KJ, Mors O. Dimensions of temperament and character as predictors of antidepressant discontinuation, response and adverse reactions during treatment with nortriptyline and escitalopram. Psychological Medicine. 1-9. PMID 34763734 DOI: 10.1017/S003329172100444X |
0.157 |
|
| 2006 |
Shivakumar K, Mir A, McAllister VDM, O'Keane V, Aitchison KJ. Aripiprazole in psychotic depression: Four case reports Clinical Neuropsychiatry. 3: 332-337. |
0.153 |
|
| 2008 |
Ohlsen RI, Taylor D, Tandon K, Aitchison KJ. Returning to the issue of the cost-effectiveness of antipsychotics in the treatment of Schizophrenia Clinical Neuropsychiatry. 5: 184-194. |
0.15 |
|
| 2021 |
Yap S, Luki J, Hanstock CC, Seres P, Shandro T, Hanstock SEC, Lirette A, Zhao HH, Aitchison KJ, Le Melledo JM. Decreased Medial Prefrontal Cortex Glutamate Levels in Perimenopausal Women. Frontiers in Psychiatry. 12: 763562. PMID 34966302 DOI: 10.3389/fpsyt.2021.763562 |
0.149 |
|
| 2018 |
Lodhi RJ, Wang Y, Rossolatos D, MacIntyre G, Bowker A, Crocker C, Ren H, Dimitrijevic A, Bugbee DA, Loverock A, Majeau B, Sivapalan S, Newton VM, Tibbo P, Purdon SE, ... Aitchison KJ, et al. Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis use. Brain and Behavior. 8: e01120. PMID 30264447 DOI: 10.1002/brb3.1120 |
0.148 |
|
| 2021 |
Chan EC, Sun Y, Aitchison KJ, Sivapalan S. Mobile App-Based Self-Report Questionnaires for the Assessment and Monitoring of Bipolar Disorder: Systematic Review. Jmir Formative Research. 5: e13770. PMID 33416510 DOI: 10.2196/13770 |
0.145 |
|
| 2009 |
Aitchison KJ, McGuffin P. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression (British Journal of Psychiatry 194, (252-259)) British Journal of Psychiatry. 195: 87. DOI: 10.1192/bjp.195.1.87a |
0.137 |
|
| 2020 |
Bousman CA, Bengesser SA, Aitchison KJ, Amare AT, Aschauer H, Baune BT, Asl BB, Bishop JR, Burmeister M, Chaumette B, Chen LS, Cordner ZA, Deckert J, Degenhardt F, DeLisi LE, et al. Review and Consensus on Pharmacogenomic Testing in Psychiatry. Pharmacopsychiatry. PMID 33147643 DOI: 10.1055/a-1288-1061 |
0.136 |
|
| 2022 |
Henriques BC, Buchner A, Hu X, Wang Y, Yavorskyy V, Wallace K, Dong R, Martens K, Carr MS, Asl BB, Hague J, Sivapalan S, Maier W, Dernovsek MZ, Henigsberg N, ... ... Aitchison KJ, et al. Correction: Methodology for clinical genotyping of CYP2D6 and CYP2C19. Translational Psychiatry. 12: 94. PMID 35260547 DOI: 10.1038/s41398-022-01845-w |
0.135 |
|
| 2022 |
Tran KH, Luki J, Hanstock S, Hanstock CC, Seres P, Aitchison K, Shandro T, Le Melledo JM. Decreased GABA+ levels in the medial prefrontal cortex of perimenopausal women: a 3T 1H-MRS study. The International Journal of Neuropsychopharmacology. PMID 36146906 DOI: 10.1093/ijnp/pyac066 |
0.13 |
|
| 2023 |
Tran KH, Luki J, Hanstock S, Hanstock CC, Seres P, Aitchison K, Le Melledo JM. Decreased GABA+ ratios referenced to creatine and phosphocreatine in the left dorsolateral prefrontal cortex of females of reproductive age with major depression. Journal of Psychiatry & Neuroscience : Jpn. 48: E285-E294. PMID 37607825 DOI: 10.1503/jpn.230016 |
0.126 |
|
| 2021 |
McKee KA, Hmidan A, Crocker CE, Lam RW, Meyer JH, Crockford D, Trépanier A, Aitchison KJ, Tibbo PG. Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials. Journal of Psychiatric Research. 140: 267-281. PMID 34119912 DOI: 10.1016/j.jpsychires.2021.05.044 |
0.126 |
|
| 2021 |
Buchner A, Hu X, Aitchison KJ. Validation of Single Nucleotide Variant Assays for Human Leukocyte Antigen Haplotypes and Across Diverse Ancestral Backgrounds. Frontiers in Pharmacology. 12: 713178. PMID 34381365 DOI: 10.3389/fphar.2021.713178 |
0.123 |
|
| 2012 |
Tsapakis EM, Curran S, Ohlsen RI, Vyas NS, Aitchison KJ, Daly AK. Pharmacogenetics in Psychiatry Pharmacogenetics and Individualized Therapy. 215-250. DOI: 10.1002/9781118116494.ch7 |
0.121 |
|
| 2022 |
Buchner A, Hu X, Aitchison KJ. Corrigendum: Validation of single nucleotide variant assays for human leukocyte antigen haplotypes HLA-B*15:02 and HLA-A*31:01 across diverse ancestral backgrounds. Frontiers in Pharmacology. 13: 971316. PMID 35991872 DOI: 10.3389/fphar.2022.971316 |
0.104 |
|
| 2022 |
Tran KH, Luki J, Hanstock S, Hanstock CC, Seres P, Aitchison K, Shandro T, Le Melledo JM. A comparative magnetic resonance spectroscopy study of GABA+ and glutamate referenced to creatine and phosphocreatine in the left dorsolateral prefrontal cortex of perimenopausal women and women of reproductive age. Frontiers in Psychiatry. 13: 989050. PMID 36386999 DOI: 10.3389/fpsyt.2022.989050 |
0.103 |
|
| 2011 |
Aitchison KJ, Malhotra AK. The Ninth Annual Pharmacogenetics in Psychiatry Meeting report. Psychiatric Genetics. 21: 112-3. PMID 21206402 DOI: 10.1097/YPG.0b013e328341e07e |
0.101 |
|
| 2008 |
Cratsley K, Regan J, McAllister V, Simic M, Aitchison KJ. Duration of Untreated Psychosis, Referral Route, and Age of Onset in an Early Intervention in Psychosis Service and a Local CAMHS. Child and Adolescent Mental Health. 13: 130-133. PMID 32847178 DOI: 10.1111/j.1475-3588.2007.00467.x |
0.095 |
|
| 2022 |
Jiang S, Wallace K, Yang E, Roper L, Aryal G, Lee D, Lodhi RJ, Arnau R, Isenberg R, Green B, Wishart D, Aitchison KJ. Logistic Regression With Machine Learning Sheds Light on the Problematic Sexual Behavior Phenotype. Journal of Addiction Medicine. PMID 36193910 DOI: 10.1097/ADM.0000000000001078 |
0.095 |
|
| 1987 |
Ogilvie DJ, Aitchison K, Sykes BC. An RFLP close to the human collagen I gene COL1A1. Nucleic Acids Research. 15: 4699. PMID 2884632 DOI: 10.1093/NAR/15.11.4699 |
0.094 |
|
| 2021 |
Bousman CA, Wu P, Aitchison KJ, Cheng T. Sequence2Script: A Web-Based Tool for Translation of Pharmacogenetic Data Into Evidence-Based Prescribing Recommendations. Frontiers in Pharmacology. 12: 636650. PMID 33815120 DOI: 10.3389/fphar.2021.636650 |
0.09 |
|
| 2024 |
Tran KH, Luki J, Hanstock S, Hanstock CC, Seres P, Aitchison K, Shandro T, Le Melledo JM. The impact of matching for reproductive status on the comparison of magnetic spectroscopic measurements of glutamate and gamma-aminobutyric acid + in the medial prefrontal cortex of women with major depression. Journal of Affective Disorders. PMID 38244791 DOI: 10.1016/j.jad.2024.01.140 |
0.088 |
|
| 2008 |
Evangelia TM, Aitchison KJ. Biological treatments: General considerations Essential Psychiatry, Fourth Edition. 567-585. DOI: 10.1017/CBO9780511544125.026 |
0.077 |
|
| 2021 |
Chan EC, Wallace K, Yang EH, Roper L, Aryal G, Lodhi RJ, Baskys A, Isenberg R, Carnes P, Green B, Aitchison KJ. Internal consistency and concurrent validity of self-report components of a new instrument for the assessment of suicidality, the Suicide Ideation and Behavior Assessment Tool (SIBAT). Psychiatry Research. 304: 114128. PMID 34343876 DOI: 10.1016/j.psychres.2021.114128 |
0.071 |
|
| 2021 |
Chan EC, Wallace K, Yang EH, Roper L, Aryal G, Lodhi RJ, Isenberg R, Carnes P, Baskys A, Green B, Aitchison KJ. The feasibility and acceptability of mobile application-based assessment of suicidality using self-report components of a novel tool, the Suicide Ideation and Behavior Assessment Tool (SIBAT). Psychiatry Research. 307: 114316. PMID 34896843 DOI: 10.1016/j.psychres.2021.114316 |
0.061 |
|
| 2014 |
Hudson AL, Lalies MD, Baker GB, Wells K, Aitchison KJ. Ecstasy, legal highs and designer drug use: A Canadian perspective Drug Science, Policy and Law. 1: 205032451350919. DOI: 10.1177/2050324513509190 |
0.056 |
|
| 2008 |
McCrone P, Aitchison KJ, Taylor D. How far have we got in pharmacoeconomics for psychiatry and where are we going? Clinical Neuropsychiatry. 5: 173-174. |
0.05 |
|
| 2023 |
Brown LC, Allen JD, Eyre HA, Baune BT, Aitchison KJ, Bousman CA. Editorial: Precision psychiatry from a pharmacogenetics perspective. Frontiers in Psychiatry. 14: 1159000. PMID 36937716 DOI: 10.3389/fpsyt.2023.1159000 |
0.035 |
|
| 2009 |
Aitchison KJ. Disclosure of religious beliefs. The British Journal of Psychiatry : the Journal of Mental Science. 195: 368; author reply 36. PMID 19794209 DOI: 10.1192/bjp.195.4.368b |
0.025 |
|
| 2008 |
Romeo R, Aitchison KJ, Capdevielle D. Pharmacogenetic testing in psychiatry: Pharmacoeconomic applications and considerations Clinical Neuropsychiatry. 5: 206-211. |
0.025 |
|
| 2015 |
Fu CH, Legge RM, Cohen-Woods S, Cole JH, Aitchison KJ, McGuffin P. Authors' reply. The British Journal of Psychiatry : the Journal of Mental Science. 207: 363-4. PMID 26429689 DOI: 10.1192/bjp.207.4.363a |
0.012 |
|
| 2010 |
Keers R, Farmer AE, Aitchison KJ. The authors reply Psychological Medicine. 40: 702-704. DOI: 10.1017/S0033291710000012 |
0.012 |
|
| Hide low-probability matches. |